Pet Tech: what are the top startups?
In our Pet Tech market deck, you will find everything you need to understand the market
SUMMARY
Pet Tech: what are the top startups? The strongest startups today are the ones turning pet ownership into healthcare, insurance, nutrition, clinic infrastructure, and health-data systems.
The market is no longer rewarding “cute pet app” logic. The clearest recent funding signals are going into insurance, veterinary care, clinic software, fresh nutrition infrastructure, and regulated animal health.
Lassie is the strongest funding signal because its $75 million Series C points to prevention-first pet insurance becoming a real care platform, not just a claims product.
Modern Animal matters because it has operating proof, not only investor proof. A $100 million annual revenue run rate makes it one of the rare pet-care startups with visible scale behind the story.
The science-heavy side is thinner, but more interesting. Loyal stands out because its FDA milestone gives pet longevity a regulatory signal that most wellness or biotech-adjacent startups cannot match.
Veterinary workflow looks like one of the cleanest software opportunities in pet tech. Digitail, Scribenote, and PetsApp are not selling novelty features; they are trying to remove work from clinics that already feel labor pressure every day.
Pet wearables are splitting into clear subcategories. Tractive leads on scale, Fi pushes behavior AI, PetPace goes clinical, and Catlog shows why cats deserve their own monitoring logic.
Connected pet devices are becoming more valuable when they sit next to unavoidable behaviors. Litter use, eating, drinking, movement, and scratching create better health signals than a camera that only captures cute moments.
Fresh pet food is still exciting, but only where companies can prove scale, production capacity, category share, or profitability. The Farmer’s Dog, Butternut Box, and KatKin look stronger than generic DTC food brands because they have harder operating signals.
India is becoming a serious pet-tech market, but with different proof points. Supertails, Heads Up For Tails, and Dogsee Chew show that the opportunity mixes commerce, premium retail, services, and export brands rather than one single software category.
The biggest pattern is that fresh proof beats old fame. Petcube, Pawp, and older telehealth or camera names still matter historically, but the current leaders are the ones with recent funding, revenue, regulatory progress, infrastructure, usage, or distribution proof.
So the best current list is not one category winner but a portfolio of category leaders: Lassie, Modern Animal, Tractive, The Farmer’s Dog, Whisker, Loyal, Digitail, Supertails, Butternut Box, KatKin, Airvet, Fi, Gallant, PETKIT, Scribenote, and Heads Up For Tails.
This market map, featured in our Pet Tech market deck, highlights top companies and startups in the pet tech market
Which pet-tech startups are actually getting funded right now?
In current pet tech, the strongest funding signals are Lassie, Modern Animal, Supertails, Digitail, Butternut Box, KatKin, Loyal, Gallant, and Airvet.
The interesting part is not just that they raised money but where the money went. Investors are putting fresh capital into pet insurance, veterinary care, clinic software, fresh nutrition infrastructure, and regulated animal health. That says a lot about the market. The heat has moved away from simple gadgets and toward health, care, and recurring services.
Lassie is the clearest funding winner. In February 2026, Balderton announced that the Swedish pet insurer had raised a $75 million Series C. That round is bigger than the recent rounds we see for most pet-commerce, pet-device, or vet-software startups. Lassie also has a sharper story than a normal insurer: it wants to reward prevention, use pet-health data, and make insurance feel like a daily care product rather than something you only touch after a claim.
Modern Animal is the strongest operating-scale signal. In September 2025, the company announced $46 million in new funding and said it had reached a $100 million annual revenue run rate. That is a very different proof point from “we raised a nice round.” It says the company already has a meaningful clinic network and paying demand. Compared with earlier pet-care startups that were mostly telehealth or booking layers, Modern Animal has the harder asset: real veterinary capacity.
Supertails is the hottest India signal, but it is not clean yet. Entrackr reported in March 2026 that Supertails crossed ₹108.3 crore in FY25 operating revenue, up 68% year over year. That is strong growth for an Indian petcare platform founded only a few years ago. But the same filings showed losses widening to ₹52.5 crore. So we should rank Supertails as a high-growth emerging-market leader, not as a proven profitability story.
Digitail is the most convincing pure software raise. In November 2025, the company announced a $23 million Series B led by Five Elms Capital, bringing total funding above $37 million. This is an important point. Veterinary software is a better business than many consumer pet apps: clinics have painful workflows, recurring software budgets, and clear labor shortages. Digitail is not selling a nice-to-have pet-parent feature. It is trying to become daily infrastructure for veterinary teams.
Butternut Box and KatKin show that fresh pet food is still fundable, but only at real scale. Butternut Box secured more than €75 million of debt financing in May 2025 to support a second manufacturing facility in Poland. KatKin raised $50 million in late 2025 and said it had sold more than 100 million fresh meals while reaching 2% of the UK cat-food market. These signals prove that the fresh-food winners are now being judged on production capacity, category share, and logistics.
Loyal and Gallant are the science-heavy bets. Loyal’s February 2025 FDA milestone for LOY-002 gives it a stronger proof point than most “pet longevity” stories. Gallant’s June 2025 $18 million Series B for ready-to-use stem-cell therapies is earlier and riskier, but it is still a real animal-health biotech signal.
Airvet is smaller, but strategically sharp. Its April 2025 $11 million round came with a claim of more than 4x year-over-year enterprise ARR growth. That makes it more interesting than many DTC pet telehealth names because employer distribution can lower acquisition friction.
So today, the funding market is basically telling us one thing: pet tech is becoming pet healthcare infrastructure.
Which pet-health startups could become real medicine companies?
In pet biotech and regulated animal health, Loyal is the clear leader, Gallant is the serious challenger, and PetMedix is the strategic proof case.
Loyal is ahead because it has the rarest signal in this category: regulatory progress. In February 2025, the FDA’s Center for Veterinary Medicine accepted the reasonable expectation of effectiveness section for LOY-002, Loyal’s daily pill for senior dog lifespan extension.
That is not full approval, and we should not pretend it is. But, to be honest, it is much stronger than a biotech startup saying it has “promising science.”
The comparison with Gallant is useful. Gallant is ambitious, but Loyal is further along on public regulatory proof. Gallant raised $18 million in June 2025 to develop off-the-shelf stem-cell therapies for pets. That is a serious category-creation attempt, but the signal is still mostly funding plus pipeline direction. Loyal has funding too, but the FDA milestone gives us more reason to rank it first.
PetMedix is different because it is no longer an independent startup after Zoetis acquired it. Still, it matters as a market signal. Its pet-specific monoclonal antibody work showed that large animal-health incumbents will buy credible science platforms when the technology is strong enough.
The category is still thin. We do not yet see ten obvious winners. But that is exactly why Loyal stands out so much. In a field full of claims, it has a dated regulatory milestone that lets us be more confident than usual.
If you want more recent data on this point, please see our latest Pet Tech market report.
As this chart shows, and as featured in our Pet Tech market deck, search interest in pet cameras has risen sharply
Which startups are now fixing the vet clinic, not just making another pet app?
For veterinary workflow in pet tech, Digitail leads the software platform race, Scribenote has the best AI-scribe wedge, and PetsApp remains relevant because of usage scale.
Digitail is the strongest full-platform candidate. Its November 2025 Series B was not huge compared with Lassie or Modern Animal, but in vet software, $23 million is meaningful. More importantly, Digitail is going after the operating system layer: practice management, records, automation, pet-parent communication, and AI support for clinics.
Scribenote is narrower, but the wedge is very clean. In September 2024, it raised $8.2 million led by a16z for an AI medical scribe built for veterinarians. The reason it deserves a high rank is simple: documentation is one of the most obvious pain points in vet clinics. If a product saves time every day, the value is easier to prove than a generic “AI pet assistant.”
PetsApp is not the freshest funding story, but it has scale that newer AI tools still need to earn. The company says it has 6.3 million pets registered, more than $13 million in transactions processed, and over 15,000 veterinary professionals on the platform. That does not automatically make it the most exciting AI company, but it does mean it already sits inside real clinic-client workflows.
The hierarchy is pretty clear now. Digitail has the broadest platform ambition. Scribenote has the sharpest AI wedge. PetsApp has the strongest existing communication footprint. And compared with consumer pet apps, all three are playing in a better market because clinics have urgent labor problems and clearer willingness to pay.
At the end of the day, the best AI pet-tech companies are not the ones chatting with owners for fun but the ones removing admin work from veterinary teams.
Which pet wearables are more than GPS trackers now?
In pet wearables, Tractive is the scale leader, Fi is the AI-behavior challenger, PetPace is the clinical-monitoring specialist, and Catlog is the cat-specific name to watch.
Tractive is still the company to beat. In July 2025, it acquired Whistle from Mars Petcare, and the company said it served more than 1.4 million active users.
The thing is: wearables are a scale game. You need hardware, subscriptions, support, data, and low churn. Tractive is not just selling devices: it has also built a subscription base large enough to absorb a former Mars-owned competitor.
Fi is the more interesting challenger because it is trying to move the category from location to behavior. In June 2025, The Verge reported that Fi’s Series 3 Plus collar added behavior detection for barking, licking, scratching, eating, and drinking, with Fi claiming 80% accuracy. That gives Fi a different angle from older trackers. If the behavior detection improves, the product becomes less about “where is my dog?” and more about “is something changing in my dog?”
PetPace is smaller in consumer awareness, but more clinical in positioning. Its September 2025 V3.0 collar launch focused on 24/7 monitoring and telehealth connectivity. That makes it more relevant for sick, senior, post-operative, or high-risk pets than for casual tracking.
Catlog is worth mentioning because cats are underserved in wearables. In February 2025, Japan’s RABO raised 800 million yen and said it would expand from cat-health devices into dog-oriented devices. Cat monitoring is harder than dog monitoring because cats hide symptoms better and owners observe fewer outdoor behaviors. That makes passive data more valuable.
So the category splits neatly. Tractive wins on scale. Fi wins on fresh consumer-AI momentum. PetPace wins on clinical depth. Catlog wins on cat-specific focus. A generic GPS collar startup without one of those advantages is much harder to get excited about today.
If you want more recent data on this point, please see our latest Pet Tech market report.
This chart, included in our Pet Tech market deck, shows annual VC investment in pet tech startups
Which connected pet devices are becoming a health-data layer?
In connected pet devices, Whisker is the clearest leader, while PETKIT is the most interesting fresh product challenger.
Whisker is strong because it starts from a behavior owners already have to deal with every day: litter. In October 2025, Whisker launched the Litter-Robot 5 Pro, an $899 AI litter box with dual cameras, facial recognition for multi-cat homes, and waste monitoring. Forbes and The Verge both covered the launch, and Whisker’s own product page now pushes individualized cat insights as a core feature.
That is a better data position than a camera sitting in a living room. A litter box can capture weight, frequency, urine and stool patterns, and changes by individual cat. Those are actual health signals, not just cute video moments.
PETKIT is not as dominant as Whisker, but its CES 2026 products show where the category is going. Its new wet-food feeder and water fountain add cameras, pet recognition, eating data, and drinking data. The most interesting part is not the hardware itself but the idea that feeding and hydration devices could become recurring nutrition and health-monitoring infrastructure.
Petcube is the name many readers will know, but it does not rank as highly here anymore. It helped define connected pet cameras, but the freshest evidence is weaker than Whisker’s AI litter launch or PETKIT’s move into feeding and hydration intelligence.
So it looks like the connected-device race is moving from entertainment to diagnostics. The winners will be the devices that sit next to unavoidable pet behaviors: eating, drinking, sleeping, litter use, movement, scratching, and medication.
Which pet-insurance startups are becoming real care platforms?
In pet insurance, Lassie is the current leader, while Dalma and Napo are the European challengers to watch.
Lassie is the easiest call in this article. In February 2026, Balderton announced its $75 million Series C. The company also points to partnerships with Lidl and Tractive, which is important because prevention-first insurance only works if the insurer can touch pet owners outside the claims moment.
Dalma is smaller but sharp. In March 2025, EU-Startups reported that the French company raised €20 million Series B to grow its pet-insurance model, including AI-supported claims and 24/7 veterinary access. The positioning is close to Lassie, but the proof is lighter: smaller round, less public scale, and a more local starting position.
Napo is the UK challenger. In February 2025, it raised €14.4 million Series B, with a focus on AI and automation. It also emphasizes broad coverage, dental care, and access to video vets and behaviorists. That makes it credible, but still below Lassie on current evidence.
The ranking is not complicated. Lassie has the biggest recent capital signal and the clearest prevention-first platform story. Dalma and Napo show that the same shift is happening across Europe, but they have not yet produced the same level of public proof.
As things stand, pet insurance is becoming less about reimbursement and more about daily care, claims automation, prevention, and partner distribution. Lassie is furthest along on that story today.
If you want more recent data on this point, please see our latest Pet Tech market report.
This chart, included in our Pet Tech market deck, looks at Tractive’s strategy in pet tech
Which fresh pet-food startups are still exciting after the DTC hype cooled?
In fresh pet food, The Farmer’s Dog is the US scale benchmark, Butternut Box is the European infrastructure winner, and KatKin is the strongest cat-specific breakout.
The Farmer’s Dog sits in a different tier because of revenue and profitability. In March 2025, PitchBook reported that the company had passed $1 billion in annualized revenue and was generating more than $10 million in monthly profits, according to a person familiar with the business. Even if we treat that as reported private-company information, it is still the strongest financial signal in fresh pet food.
That makes the comparison with Butternut Box useful. Butternut Box is not proving itself through disclosed profitability. It is proving itself through infrastructure. In May 2025, it secured more than €75 million in debt financing to support a second manufacturing facility in Poland. In fresh pet food, that matters because the hardest part is not writing a nice brand story. It is manufacturing, cold-chain logistics, personalization, and retention.
KatKin is the most interesting because it focuses on cats, not dogs. In late 2025, KatKin said it had sold more than 100 million fresh meals and reached 2% of the UK cat-food market while raising $50 million. That is a better signal than “cat food is underpenetrated.” It gives us an actual market-share marker in a category where dogs usually get most of the attention.
Ollie still belongs in the conversation as a known US fresh-dog-food brand, but the fresh evidence is not as strong as The Farmer’s Dog. Without a recent revenue or profitability marker of similar quality, it should not be ranked in the same tier.
Dogsee Chew is different because it is more natural treats than fresh meals. Still, its February 2025 $8 million Series B and presence in more than 30 countries make it a credible emerging-market export story.
Which startups are making India a serious pet-tech market?
In Indian pet tech, Supertails is the digital platform leader, Heads Up For Tails is the premium retail leader, and Dogsee Chew is the export-oriented challenger.
Supertails gets the top spot because it combines recent funding with recent financial data. Its $30 million raise in February 2026 showed investor appetite. Its FY25 filings showed ₹108.3 crore in operating revenue, up 68% year over year. That is the good part. The harder part is that losses widened to ₹52.5 crore, and most revenue still came from commerce rather than services.
That tells us exactly how to read Supertails. It is a fast-growing pet-commerce and care platform, but the “full-stack care” story still needs more financial proof. Today, it looks more like a commerce-led platform with services attached than a services-led healthcare company.
Heads Up For Tails is a different kind of leader. GlobalPETS reported in January 2026 that it raised $25 million in Series B funding, with expansion into the Middle East in focus. It has stronger premium retail and brand DNA than Supertails. That makes it less software-like, but potentially stronger in merchandising, offline trust, and premium customer relationships.
Dogsee Chew is smaller but globally interesting. Its February 2025 Series B came with a reported presence in more than 30 countries. That makes it less of an India-only pet story and more of a natural-treat export story.
The comparison is useful: Supertails is the platform bet, Heads Up For Tails is the premium omnichannel bet, and Dogsee Chew is the export-brand bet. India’s pet-tech market is still early, but these three show it is no longer just a small local retail category.
This chart, included in our Pet Tech market deck, shows annual funding in pet tech startups
Which startups are selling pet care through employers instead of fighting DTC CAC?
In pet-benefits and virtual care, Airvet is the cleanest employer-distribution play, while Modern Animal proves the broader subscription-care model has real revenue behind it.
Airvet is interesting because it avoids one of the ugliest problems in pet tech: paying to acquire individual pet parents one by one. In April 2025, Airvet announced $11 million in new funding and said enterprise ARR had grown more than 4x year over year. That is a strong signal because it points to employers paying for pet care as part of benefits.
That puts Airvet ahead of many telehealth names for this angle. A DTC pet telehealth app might get occasional usage when an owner is worried. An employer-benefits platform can be distributed through HR, bundled into benefits, and used before a crisis. It is a cleaner route to recurring revenue.
Modern Animal belongs here too, but for a different reason. As seen above, its September 2025 $100 million run-rate announcement gives us proof that membership-style, tech-enabled care can reach real scale. It is not the same model as Airvet, but it supports the same idea: pet care is becoming a recurring access product.
Dutch, Pawp, and Vetster remain relevant, but the current evidence is less decisive. Dutch’s May 2025 partnership with PetMed Express is a useful signal that pharmacy and telehealth are converging. Pawp and Vetster are still known names, but without comparable fresh revenue or enterprise-growth proof, they should not lead this category.
Everything considered, employer distribution looks underrated. It can turn pet care from an anxious one-off consumer purchase into a predictable benefits product.
If you want more recent data on this point, please see our latest Pet Tech market report.
Which pet-tech startups are still too famous for the evidence they have now?
In current pet tech, Petcube, Pawp, and some older camera or telehealth names still have recognition, but weaker fresh momentum than the leaders above.
This part matters because many “top pet startups” lists recycle the same names. Brand recognition is not the same as current leadership.
Petcube is the clearest example. It helped define the connected pet-camera category. But if we compare recent signals, Whisker’s 2025 AI litter launch is stronger, PETKIT’s CES 2026 feeding and hydration products feel more current, and Fi’s 2025 collar update has a clearer health-monitoring angle. Petcube is still relevant, but it does not look like the hottest connected-device startup today.
Pawp is similar. It was an early, visible name in pet telehealth and membership care. But its major funding moment was back in 2021. Compared with Airvet’s 2025 enterprise ARR growth or Modern Animal’s 2025 revenue run-rate disclosure, Pawp has less fresh public proof.
Generic GPS trackers and pet cameras also look weaker now unless they can prove health monitoring, subscription retention, clinical relevance, or distribution scale. A few years ago, “connected pet device” sounded exciting by itself. These days, the bar is higher.
So it looks like some known pet-tech names are still known because they were early, not because they are the strongest companies right now.
This chart, included in our Pet Tech market deck, compares the main business model options for pet GPS wearable companies
Which startups should we actually call the top pet-tech startups today?
We can confidently say that the top pet-tech startups right now are Lassie, Modern Animal, Tractive, The Farmer’s Dog, Whisker, Loyal, Digitail, Supertails, Butternut Box, KatKin, Airvet, Fi, Gallant, PETKIT, Scribenote, and Heads Up For Tails.
That is the final list after comparing the angles.
Lassie is the top pet-insurance startup because it has the biggest recent funding signal and the clearest prevention-first platform model. Modern Animal is one of the strongest vet-care startups because it has a $100 million annual run-rate proof point. Tractive is the wearable leader because it has scale, active users, and a 2025 acquisition of Whistle from Mars Petcare.
The Farmer’s Dog is the fresh-food benchmark because reported revenue and profitability put it in a different league. Whisker is the connected-device leader because it sits on daily cat-health data, not just entertainment. Loyal is the highest-upside animal-health biotech because the FDA milestone makes its longevity claim much more concrete than the usual wellness language.
Digitail and Scribenote matter because AI in vet clinics is already useful when it saves labor. Airvet matters because employer distribution gives pet telehealth a more efficient route to recurring revenue. Supertails and Heads Up For Tails matter because India is now producing pet-tech companies with real revenue, funding, and expansion plans. Butternut Box and KatKin matter because fresh food is becoming an infrastructure game. Fi, PETKIT, PetPace, and Catlog show that devices now need to become health-data products.
So, the top pet-tech startups today are the ones turning pet ownership into a healthcare, insurance, nutrition, clinic, and data-infrastructure market. Fame still helps, but fresh proof matters more.
If you want more recent data on this point, please see our latest Pet Tech market report.
| Category | Startups selected and why |
|---|---|
| Fresh funding heat | Lassie, Modern Animal, Supertails, Digitail, Butternut Box, KatKin, Loyal, Gallant, Airvet. These companies have the strongest 2025–2026 funding or operating signals across insurance, care, software, nutrition, biotech, and benefits. |
| Regulated pet medicine | Loyal leads because of FDA RXE progress for LOY-002. Gallant is the challenger because of its 2025 Series B for off-the-shelf stem-cell therapies. |
| Vet workflow and AI | Digitail leads on full-platform ambition. Scribenote leads on AI-scribe focus. PetsApp stays relevant because of clinic and pet-parent usage scale. |
| Smart collars and wearables | Tractive leads on scale and the Whistle acquisition. Fi leads on fresh consumer AI behavior tracking. PetPace leads on clinical monitoring. Catlog is the cat-specific watchlist name. |
| Connected health devices | Whisker leads because litter data is health-relevant and frequent. PETKIT is the fresh challenger because feeding and hydration devices are becoming data products. |
| Pet insurance | Lassie leads by a wide margin. Dalma and Napo are credible European challengers, but their public proof is smaller. |
| Fresh pet food | The Farmer’s Dog leads on reported revenue and profitability. Butternut Box leads on European manufacturing infrastructure. KatKin leads on cat-specific fresh food. |
| Indian pet tech | Supertails is the platform leader. Heads Up For Tails is the premium retail leader. Dogsee Chew is the export-oriented natural-treat challenger. |
| Employer pet benefits | Airvet is the cleanest employer-distribution startup. Modern Animal supports the broader recurring-care thesis with stronger revenue proof. |
This chart, featured in our Pet Tech market deck, illustrates revenue distribution by customer segment in the pet tech market
OUR METHODOLOGY
This analysis tests which pet-tech startups deserve to be called the top startups today based on the evidence available now. We compare funding momentum, operating scale, regulatory progress, usage signals, product launches, infrastructure investment, distribution strategy, category share, and regional growth.
We treated “top pet-tech startups” as a broad market question, not a single funding-ranking question. The label can point to pet insurance, veterinary care, clinic software, fresh food, connected devices, regulated medicine, employer benefits, or regional platforms.
So we broke the market into the dimensions that make the question easier to answer. For each one, we looked at recent signals, compared the most relevant companies inside that context, and weighted the evidence by what it actually showed.
We gave more weight to fresh, checkable proof than to older brand recognition. A startup with recent revenue, funding, regulatory progress, infrastructure expansion, usage scale, or distribution proof ranked above a more famous name with weaker current evidence.
Funding was not treated as enough on its own. We looked at where the capital went and whether the round supported a stronger market thesis: prevention-first insurance, real veterinary capacity, clinic infrastructure, fresh-food production, regulated animal health, or employer-distributed care.
Operating scale mattered when companies disclosed credible revenue, profitability, active-user, transaction, market-share, or enterprise-growth signals. Those signals helped separate current category leaders from startups that are still mostly narrative.
For animal-health biotech and pet medicine, we weighted regulatory progress more heavily than general wellness positioning. That is why Loyal stands out: its FDA RXE milestone is a more concrete signal than a normal pet-longevity claim.
For connected devices and wearables, we focused on whether the product is becoming a health-data layer. Devices tied to daily behaviors such as litter use, eating, drinking, movement, scratching, and clinical monitoring were treated as stronger than generic cameras or GPS trackers.
For India and emerging-market pet tech, we compared companies across commerce, premium retail, export brands, care services, funding, and revenue growth. The goal was to avoid forcing the market into a US-style software-only lens.
Key sources used for this analysis include: Balderton on Lassie’s $75 million Series C, Modern Animal on its $100 million annual revenue run rate and funding, Entrackr on Supertails’ FY25 revenue and losses, Digitail on its $23 million Series B, UKTN on Butternut Box’s debt financing and Poland facility, Petfood Industry on KatKin’s $50 million raise, 100 million meals, and 2% UK cat-food market share, Business Wire on Loyal’s FDA RXE milestone, Gallant on its $18 million Series B, Airvet on its $11 million round and enterprise ARR growth, Scribenote on its $8.2 million AI veterinary scribe round, Tractive on its Whistle acquisition, Petfood Industry on Tractive’s active-user scale, The Verge on Fi’s Series 3 Plus AI behavior detection, Whisker on Litter-Robot 5 Pro, The Verge on Whisker’s Litter-Robot 5 Pro launch, The Verge on PETKIT’s CES 2026 feeding and hydration devices, Tech.eu on Dalma’s €20 million Series B, EU-Startups on Napo’s €14.4 million Series B, PitchBook on The Farmer’s Dog’s reported annualized revenue and monthly profits, GlobalPETS on Heads Up For Tails’ $25 million Series B, YourStory on Dogsee Chew’s $8 million Series B and 30-country presence, The Bridge on Catlog/RABO’s 800 million yen raise, and PetMed Express on its partnership with Dutch.
This chart, included in our Pet Tech market deck, shows how pet telehealth app technology has evolved over time
Related blog posts
- How strong is fundraising in the Pet Tech market right now?
- Which startups have raised the most funding in the Pet Tech market?
- Which startups are the most valued in the Pet Tech market?
